Page last updated: 2024-08-24

oseltamivir and probenecid

oseltamivir has been researched along with probenecid in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (70.00)	29.6817
2010's	2 (20.00)	24.3611
2020's	1 (10.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Barrett, J; Cihlar, T; Hill, G; Ho, ES; Liu, B; Oo, C; Prior, K; Ward, P; Wiltshire, H	1
Butler, D	1
Howton, JC	1
Boak, LM; Chanu, P; Gieschke, R; Jonsson, EN; Rayner, CR	1
Cunningham, F; Davey, RT; Deyton, LR; Goetz, MB; Holodniy, M; Lee, KK; Lin, ET; Olivo, N; Penzak, SR; Raisch, DW; Straight, TM	1
Davies, G; Day, NP; Fukuda, C; Hanpithakpong, W; Lindegårdh, N; Piyaphanee, W; Pongtavornpinyo, W; Pukrittayakamee, S; Silachamroon, U; Singhasivanon, P; Singtoroj, T; Stepniewska, K; Tarning, J; Wattanagoon, Y; White, NJ	1
Holodniy, M; Raisch, DW; Straight, TM	1
Feng, B; Litchfield, J; Mathialagan, S; Piotrowski, MA; Tess, DA; Varma, MV	1

Reviews

2 review(s) available for oseltamivir and probenecid

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Thrombocytopenia from combination treatment with oseltamivir and probenecid: case report, MedWatch data summary, and review of the literature. Pharmacotherapy, 2009, Volume: 29, Issue:8 Topics: Adverse Drug Reaction Reporting Systems; Aged; Antiviral Agents; Drug Interactions; Female; Humans; Oseltamivir; Probenecid; Thrombocytopenia	2009

Trials

2 trial(s) available for oseltamivir and probenecid

Article	Year
The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies. Drug metabolism and disposition: the biological fate of chemicals, 2002, Volume: 30, Issue:1 Topics: Acetamides; Adolescent; Adult; Amoxicillin; Animals; Antiviral Agents; Biological Transport; CHO Cells; Cimetidine; Cricetinae; Cross-Over Studies; Drug Interactions; Female; Humans; Influenza, Human; Kidney; Male; Middle Aged; Neuraminidase; Organic Anion Transport Protein 1; Oseltamivir; p-Aminohippuric Acid; Probenecid; Prodrugs	2002
Pharmacokinetics and tolerability of oseltamivir combined with probenecid. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Adult; Aged; Antiviral Agents; Chemoprevention; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Influenza, Human; Male; Middle Aged; Oseltamivir; Probenecid; Treatment Outcome	2008

Article

Year

The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies.

Drug metabolism and disposition: the biological fate of chemicals, 2002, Volume: 30, Issue:1

Topics: Acetamides; Adolescent; Adult; Amoxicillin; Animals; Antiviral Agents; Biological Transport; CHO Cells; Cimetidine; Cricetinae; Cross-Over Studies; Drug Interactions; Female; Humans; Influenza, Human; Kidney; Male; Middle Aged; Neuraminidase; Organic Anion Transport Protein 1; Oseltamivir; p-Aminohippuric Acid; Probenecid; Prodrugs

2002

Pharmacokinetics and tolerability of oseltamivir combined with probenecid.

Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

Topics: Adult; Aged; Antiviral Agents; Chemoprevention; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Influenza, Human; Male; Middle Aged; Oseltamivir; Probenecid; Treatment Outcome

2008

Other Studies

6 other study(ies) available for oseltamivir and probenecid

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Wartime tactic doubles power of scarce bird-flu drug. Nature, 2005, Nov-03, Volume: 438, Issue:7064 Topics: Acetamides; Drug Combinations; Drug Industry; Humans; Influenza, Human; Oseltamivir; Probenecid; World Health Organization	2005
Probenecid with oseltamivir for human influenza A (H5N1) virus infection? The New England journal of medicine, 2006, 02-23, Volume: 354, Issue:8 Topics: Acetamides; Antiviral Agents; Drug Interactions; Drug Therapy, Combination; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Oseltamivir; Probenecid	2006
Population pharmacokinetics of oseltamivir when coadministered with probenecid. Journal of clinical pharmacology, 2008, Volume: 48, Issue:8 Topics: Algorithms; Antiviral Agents; Chromatography, High Pressure Liquid; Computer Simulation; Drug Interactions; Humans; Mass Spectrometry; Nonlinear Dynamics; Oseltamivir; Population; Probenecid; Renal Agents; Software	2008
Pharmacokinetics of high-dose oseltamivir in healthy volunteers. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Administration, Oral; Adult; Antiviral Agents; Area Under Curve; Asian People; Biological Availability; Dose-Response Relationship, Drug; Drug Interactions; Female; Half-Life; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Male; Metabolic Clearance Rate; Models, Biological; Nausea; Oseltamivir; Probenecid; Saliva; Thailand; Urinalysis; Vomiting	2009
Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach. Drug metabolism and disposition: the biological fate of chemicals, 2017, Volume: 45, Issue:4 Topics: Acyclovir; Anti-Bacterial Agents; Antiviral Agents; Drug Interactions; Ganciclovir; HEK293 Cells; Humans; Kidney; Models, Biological; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Oseltamivir; Penicillin G; Probenecid; Renal Elimination; Tenofovir; Transfection	2017